Bellerophon Therapeutics
BLPH
#10112
Rank
HK$5.23 M
Marketcap
HK$0.43
Share price
0.00%
Change (1 day)
37.22%
Change (1 year)

EPS for Bellerophon Therapeutics (BLPH)

EPS in 2023 (TTM): -HK$9.47

According to Bellerophon Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$9.41. In 2022 the company made an earnings per share (EPS) of -HK$16.18 a decrease over its 2021 EPS that were of -HK$14.63.

EPS history for Bellerophon Therapeutics from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$9.47-41.46%
2022-HK$16.1810.64%
2021-HK$14.63-42.86%
2020-HK$25.6012.67%
2019-HK$22.72-500%
2018HK$5.68-103.53%
2017-HK$161.05-13.75%
2016-HK$186.73-48.13%
2015-HK$359.99882.98%
2014-HK$36.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$39.84-523.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$23.37 148.23%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$23.12-345.64%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$11.90-226.45%๐Ÿ‡บ๐Ÿ‡ธ USA